ENSILICATION
Live / Applied — Non-final action mailed (as of 25 Oct 2026)
What this means for you
Not registered yet, but its 30 Mar 2026 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 79455221
- Mark type
- Word mark
- Filed
- 30 Mar 2026
Goods and services
- Class 001 — Chemicals: Additives (chemical -) for use in enzyme stabilisation; catalysts for chemical and biochemical processes; biological activators; raw chemicals; chemical substances, chemical materials and chemical preparations; chemical adjuvants for use in industry and science; chemicals for use in the manufacture of pharmaceuticals; chemicals for use in biotechnological product development; biological preparations for use in industry; chemical substances for use in the biochemical industry; biological preparations for use in science; biological preparations for use in industry and science.
- Class 010 — Medical apparatus: Medical and veterinary apparatus and instruments; medical instruments; medical devices; medical analytical apparatus for medical purposes; medical instruments for therapeutic drug monitoring; apparatus for veterinary purposes.
- Class 042 — Scientific and technological services: Scientific and technological services and research and design relating thereto; biological and biotechnological research and analysis; product research and development; product development in the field of vaccines and vaccine research; research and development relating to pharmaceutical, biotech and vaccine products and technologies; research and development relating to drug substances, adjuvants and medicines; research and development in the field of stabilisation of biological components; development and exploitation of protective silica nanoshells for the protection and/or delivery of biological components; biotechnology testing; design and implementation of biological analysis tests in the field of vaccine research; testing of drug substances and products for the pharmaceutical, biotech and vaccine sectors; consultancy services relating to pharmaceuticals, vaccines and biotechnology; consultancy services relating to research and development of pharmaceutical, biologic, and vaccine preparations and adjuvants; provision of medical research information in the field of pharmaceuticals, biotechnology, adjuvants and vaccines; advisory services relating to research and development of pharmaceutical, biotech and vaccine products.
Owner
Prosecution history
- 25 Oct 2026 — NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
- 25 Oct 2026 — REFUSAL PROCESSED BY MPU
- 21 Aug 2026 — NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
- 20 Aug 2026 — NON-FINAL ACTION WRITTEN
- 12 Aug 2026 — ASSIGNED TO EXAMINER
- 11 Aug 2026 — APPLICATION FILING RECEIPT MAILED
- 11 Aug 2026 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 30 Jul 2026 — SN ASSIGNED FOR SECT 66A APPL FROM IB